1. Patent expiry dates for biologicals: 2016 update.;GaBI Journal Editor;GaBi J,2017
2. Saving money in the European healthcare systems with biosimilars.;Haustein;GaBi J,2012
3. The impact of biosimilar competition in Europe. Durham: IQVIA; 2017. Available from: http://www.medicinesforeurope.com/wp-content/uploads/2017/05/IMS-Biosimilar-2017_V9.pdf [cited 2018 Feb 9].
4. WHO expert committee on biological standardization. Annex 2. Guidelines on evaluation of similar biotherapeutic products (SBPs). WHO Technical Report Series no. 977. Geneva: World Health Organization; 2013. Available from: http://www.who.int/biologicals/publications/trs/areas/biological_therapeutics/TRS_977_Annex_2.pdf?ua=1 [cited 2018 Feb 9].
5. WHO standards for biotherapeutics, including biosimilars: an example of the evaluation of complex biological products.;Knezevic;Ann N Y Acad Sci,2017